Click to  Buy APeX:    

Information on this website is not intended to promote any product as a treatment or cure for any disease or medical condition.

   William Chastain, Founder-Director of Non-Profit APeX Global Disease Research Institute, was recently Presented this

 prestigious  award by Oregon Secretary of State Dennis Richardson for Humanitarian work with advanced cancer victims.

Tiny Nanorobots  travel inside the body, hunting and killing disease cells with laser-like precision. Science fiction? Read how APeX targets individual disease cells with laser like precision.

 Click Button to watch video:

Video:  Famous Beverly Hills physician presents "APeX - Cutting Edge Cancer Treatment" at the  Cancer Control Society Convention in Los Angeles.

 Click Button for Book Hi-Lites: 

 Click Button for More APeX News: 

 Click Button for Background:

Contact:  wpchastain@gmail.com    Direct phone: 503-757-8444

But, we depend on small tax deductible donations from folks like you so we can continue helping those in need.  

APeX Institute  Founder-Director Bill Chastain's background and motivation for helping others.

With Hypoxia identified as a trigger for cancer and many diseases,  APeX Focused  Direct

Oxygen Infusion  delivers an overload of active oxygen molecules directly into  cancer and disease cells to eliminate effects of hypoxia. 

APeX Research Institute is a 501 (C) 3 Non-Profit with the same fund raising credentials as Komen for the Cure. 

Click for APeX Research successes:  

​​​​Read about APeX as a virtual Fountain of Youth,  and about an amazing recovery - how one person overcame  a crippling spine injury with dedication, hard work - and APeX.

Actual Case Histories from redacted formal medical records written by independent oncologists note the power of APeX Focused Oxygen Infusion Protocol.

 APeX Cancer Research  - Direct Oxygen Infusion Protocol 

 Click Button o read Actual Cases:

APeX Institute is invited to present the game-changing science of APeX Focused Oxygen Infusion Protocol to the prestigious main stream 2018 International Cancer Treatment Conference in Oslo, Norway.

 Click for APeX and Health: 

Latest research shows that hypoxia, or lack of Oxygen, promotes the start and spread of cancer-but after $100 million and 10 years of research, Merck Drug's quest to make an APeX type anti-hypoxia drug failed clinical trials and was abandoned.